
Join to View Full Profile
675 N St Clair StSte 20-150, Galter PavilionChicago, IL 60611
Phone+1 312-695-8146
Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Hiten D. Patel, MD, MPH, is a urologist based in Chicago, IL, specializing in minimally invasive surgery and urologic oncology. He completed his education and training at Johns Hopkins University, including a residency in urology and graduated from their medical school in 2014. He further pursued a Society of Urologic Oncology fellowship at Loyola University Medical Center from 2020 to 2022. Dr. Patel is currently an Assistant Professor at Northwestern Memorial Hospital and serves as a urologist at Jesse Brown VA Medical Center. He has expertise in prostate, kidney and testicular cancer, and is knowledgeable in epidemiology and biostatistics. His recent publications cover various topics related to prostate and kidney cancer care and surgery, and he is actively involved in multiple clinical trials focusing on post-surgical outcomes and improvements in urological procedures.
Education & Training
Loyola University Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2020 - 2022
Johns Hopkins UniversityResidency, Urology, 2014 - 2020
Johns Hopkins University School of MedicineClass of 2014
Certifications & Licensure
IN State Medical License 2024 - 2027
MI State Medical License 2024 - 2027
WI State Medical License 2024 - 2027
AZ State Medical License 2024 - 2026
IL State Medical License 2020 - 2026
TX State Medical License 2024 - 2026
American Board of Urology Urology
Clinical Trials
- Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy Start of enrollment: 2017 Jul 01
- PREvention of VENous ThromboEmbolism Following Radical Prostatectomy Start of enrollment: 2017 Jul 01
- Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery Start of enrollment: 2017 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Adverse Cardiovascular Outcomes of Individuals Treated With Androgen Deprivation Therapy.Eric V Li, Austin Y Ho, Richard Bennett 4th, Jonathan Aguiar, Clarissa Wong
Urology Practice. 2025-11-01 - Cost-effectiveness of office-based, magnetic resonance imaging-guided transperineal versus transrectal prostate biopsy: An economic analysis of the PREVENT trial.Mitchell M Huang, Conor B Driscoll, Nicole Handa, B Malik Wahba, Aaron A Laviana
Cancer. 2025-11-01 - Evaluation of PI-RADS version 2.1 vs. 2.0 for detecting clinically significant prostate cancer in biopsy-naïve men.Kathryn E Fink, Mitchell M Huang, Eric V Li, Mohammad R Siddiqui, Nicole Handa
Urologic Oncology. 2025-10-30
Journal Articles
- Hospitalization and Readmission Costs After Radical Cystectomy in a Nationally Representative Sample: Does Urinary Reconstruction Matter?Hiten D Patel, Meera R Chappidi, Trinity J Bivalacqua, Gregory A Joice, Phillip M Pierorazio, Max Kates, Nikolai A Sopko, BJU International
Authored Content
- Human Penile Transplantation: An Unjustified Ethical Dilemma?June 2018
- Active Surveillance of Small Renal Masses: A Safe Management Strategy for Select PatientsApril 2018
Press Mentions
Improving Prostate Cancer Outcomes for Latino Men Through AwarenessNovember 5th, 2022
DCVAC/PCa Use Alongside Chemotherapy Shows No Additional mCRPC Survival BenefitFebruary 28th, 2022
Active Cellular Immunotherapy Disappoints in Metastatic Prostate CancerFebruary 10th, 2022- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









